239 related articles for article (PubMed ID: 30944125)
1. Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.
Lennon S; Oweida A; Milner D; Phan AV; Bhatia S; Van Court B; Darragh L; Mueller AC; Raben D; Martínez-Torrecuadrada JL; Pitts TM; Somerset H; Jordan KR; Hansen KC; Williams J; Messersmith WA; Schulick RD; Owens P; Goodman KA; Karam SD
Clin Cancer Res; 2019 Jun; 25(11):3352-3365. PubMed ID: 30944125
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.
Bhatia S; Sharma J; Bukkapatnam S; Oweida A; Lennon S; Phan A; Milner D; Uyanga N; Jimeno A; Raben D; Somerset H; Heasley L; Karam SD
Clin Cancer Res; 2018 Sep; 24(18):4539-4550. PubMed ID: 29848571
[No Abstract] [Full Text] [Related]
3. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
Bhatia S; Bukkapatnam S; Van Court B; Phan A; Oweida A; Gadwa J; Mueller AC; Piper M; Darragh L; Nguyen D; Gilani A; Knitz M; Bickett T; Green A; Venkataraman S; Vibhakar R; Cittelly D; Karam SD
Mol Carcinog; 2020 Sep; 59(9):1064-1075. PubMed ID: 32567728
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
5. Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.
Wang L; Zhang J; Wang C; Qi Y; Du M; Liu W; Yang C; Yang P
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27726217
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
Bhatia S; Oweida A; Lennon S; Darragh LB; Milner D; Phan AV; Mueller AC; Van Court B; Raben D; Serkova NJ; Wang XJ; Jimeno A; Clambey ET; Pasquale EB; Karam SD
Cancer Res; 2019 May; 79(10):2722-2735. PubMed ID: 30894369
[TBL] [Abstract][Full Text] [Related]
7. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
Masood R; Kumar SR; Sinha UK; Crowe DL; Krasnoperov V; Reddy RK; Zozulya S; Singh J; Xia G; Broek D; Schönthal AH; Gill PS
Int J Cancer; 2006 Sep; 119(6):1236-48. PubMed ID: 16615113
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients.
Fehnel KP; Penn DL; Duggins-Warf M; Gruber M; Pineda S; Sesen J; Moses-Gardner A; Shah N; Driscoll J; Zurakowski D; Orbach DB; Smith ER
Exp Mol Med; 2020 Apr; 52(4):658-671. PubMed ID: 32286515
[TBL] [Abstract][Full Text] [Related]
9. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
10. EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.
Huang X; Yamada Y; Kidoya H; Naito H; Nagahama Y; Kong L; Katoh SY; Li WL; Ueno M; Takakura N
Cancer Res; 2007 Oct; 67(20):9800-8. PubMed ID: 17942910
[TBL] [Abstract][Full Text] [Related]
11. EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment.
Bhatia S; Nguyen D; Darragh LB; Van Court B; Sharma J; Knitz MW; Piper M; Bukkapatnam S; Gadwa J; Bickett TE; Bhuvane S; Corbo S; Wu B; Lee Y; Fujita M; Joshi M; Heasley LE; Ferris RL; Rodriguez O; Albanese C; Kapoor M; Pasquale EB; Karam SD
Nat Commun; 2022 Jun; 13(1):3535. PubMed ID: 35725568
[TBL] [Abstract][Full Text] [Related]
12. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
[TBL] [Abstract][Full Text] [Related]
13. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
[TBL] [Abstract][Full Text] [Related]
14. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
[TBL] [Abstract][Full Text] [Related]
15. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.
Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T
Elife; 2020 Sep; 9():. PubMed ID: 32897857
[TBL] [Abstract][Full Text] [Related]
16. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.
Katsuta H; Fukushima Y; Maruyama K; Hirashima M; Nishida K; Nishikawa S; Uemura A
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4102-8. PubMed ID: 23696610
[TBL] [Abstract][Full Text] [Related]
17. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
[TBL] [Abstract][Full Text] [Related]
18. Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer.
Magic Z; Sandström J; Perez-Tenorio G
Int J Oncol; 2019 Dec; 55(6):1275-1286. PubMed ID: 31638179
[TBL] [Abstract][Full Text] [Related]
19. EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins.
Li L; Xu N; Zhang JF; Xu LL; Zhou X; Huang BT; Li YL; Liu XL
Int J Med Sci; 2016; 13(5):365-73. PubMed ID: 27226777
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
